Cutera Reports Third Quarter 2015 Results

BRISBANE, Calif., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ:CUTR) ("Cutera" or the "Company"), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today reported financial results for the third quarter ended September 30, 2015.

Key highlights for the third quarter of 2015 were as follows:

  • Revenue increased 23% to $23.1 million, compared to the same period last year, driven primarily by recently launched new products—enlightenTM and excel HRTM—as well as continued strong contributions from legacy products.
  • Product revenue grew 80% in North America and 35% globally.
  • Gross margin improved to 58%, from the 57% in the second quarter of 2015.
  • Net loss narrowed to $957,000, or $0.07 per diluted share, and included $1.3 million of non-cash expenses related to stock-based compensation, depreciation and amortization of intangibles.
  • Cash and investments balance as of September 30, 2015 was $47.7 million, or $3.60 per outstanding share.
  • Share repurchases during the third quarter and year-to-date of 2015 were $19.4 million and $37.1 million, respectively.

Kevin Connors, President and Chief Executive Officer of Cutera, stated, "We are pleased with our fifth consecutive quarter of double-digit revenue growth and significant progress towards profitability. Looking forward, we are well positioned to continue revenue expansion, improve operating cash flow, and expect to generate GAAP profitability in the fourth quarter of 2015 and for the full-year 2016. Our North American sales organization continues to demonstrate strong market share expansion in a growing market, as reflected by 80% Product revenue growth year-over-year to $10.8 million. Rest of World ('ROW') Product revenue declined by 5% year-over-year to $6.6 million as a result of unfavorable foreign currency exchange rates. On a constant currency basis, ROW Product revenue was up approximately 3 percent year-over-year."

Since commencement of commercial shipments in December 2014, enlighten, the Company's picosecond and nanosecond tattoo removal and benign pigmented lesion treatment laser, demonstrated global appeal and has become a major revenue contributor for the Company. In June, the Company announced its first product extension to broaden enlighten's utility for the Asian market. "We believe that our proprietary, flexible platform will allow us to further broaden technical capabilities and usher new applications for aesthetic physicians moving forward. We are pleased with the early market response and believe that we have significant opportunities to expand our global reach with this product as well," added Mr. Connors.

The third quarter gross margin of 58% exceeded Company's recent guidance. This improvement was primarily attributable to an increase in the Company's direct sales as well as a sooner than planned realization of product cost reductions. The Company's loss narrowed to $957,000, which includes $1.3 million of non-cash items for stock-based compensation, depreciation and intangible amortization. Relative to the third quarter of 2014, the Company reduced its operating loss by approximately $1.6 million, reflecting leverage in the business model.

"The third quarter financial performance was driven by our strategy based on organic revenue growth coupled with a strengthened commercial organization, which is translating to improved operating metrics. We believe, with our organization and our strong portfolio of products, we are strategically positioned to continue to increase market share in a growing market. We look forward to ending 2015 with continued momentum as we plan for an exciting 2016," concluded Mr. Connors.

Conference Call

The conference call to discuss these results is scheduled to begin at 2:00 p.m. PST (5:00 p.m. EST) on November 2, 2015. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer. The call will be broadcast live over the internet hosted at the Investor Relations section of Cutera's website, and will be archived online within one hour of its completion through 8:59 p.m. PST (11:59 p.m. EST) on November 16, 2015. In addition, you may call 1-877-705-6003 to listen to the live broadcast.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to increase revenue, reduce expenses, make productivity improvements, grow the Company's market share, realize benefits from additional investment, achieve profitability, penetrate the market, generate cash from operations, and statements regarding long-term prospects and opportunities in the laser and other energy-based equipment aesthetic market are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include those related to the Company's efforts to improve sales productivity, hire and retain qualified sales representatives, improve revenue growth, gross margins and profitability through leveraging operating expenses in the fourth quarter of 2015 and full year 2016; the Company's ability to successfully develop and launch new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to the Company's operations; government regulatory actions; and those other factors described in the section entitled, "Risk Factors" in its most recent Form 10-Q as filed with the Securities and Exchange Commission on November 2nd, 2015. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. Cutera's financial performance for the third quarter ended September 30, 2015, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

(in thousands, except per share data)
Three Months Ended
September 30, September 30,
2015 2014
Net revenue $ 23,085 $ 18,726
Cost of revenue 9,594 7,935
Gross profit 13,491 10,791
Gross margin % 58% 58%
Operating expenses:
Sales and marketing 8,790 7,805
Research and development 2,748 2,628
General and administrative 2,937 2,897
Total operating expenses 14,475 13,330
Loss from operations (984) (2,539)
Interest and other income, net 84 --
Loss before income taxes (900) (2,539)
Provision for income taxes 57 97
Net loss $ (957) $ (2,636)
Net loss per share:
Basic and diluted $ (0.07) $ (0.18)
Weighted-average number of shares used in per share calculations:
Basic and diluted 13,827 14,334
(in thousands)
September 30, June 30, September 30,
2015 2015 2014
Current assets:
Cash and cash equivalents $ 10,055 $ 11,627 $ 11,377
Marketable investments 37,689 54,708 69,321
Cash, cash equivalents and marketable investments 47,744 66,335 80,698
Accounts receivable, net 9,013 8,919 8,736
Inventories 13,479 13,521 11,106
Deferred tax asset 69 27 29
Other current assets and prepaid expenses 1,977 1,625 1,947
Total current assets 72,282 90,427 102,516
Property and equipment, net 1,386 1,512 1,301
Deferred tax asset, net of current portion 291 283 316
Intangibles, net 227 332 1,438
Goodwill 1,339 1,339 1,339
Other long-term assets 392 351 13
Total assets $ 75,917 $ 94,244 $ 106,923
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable $ 2,659 $ 3,597 $ 2,718
Accrued liabilities 12,234 10,308 8,975
Deferred revenue 8,470 8,659 8,745
Total current liabilities 23,363 22,564 20,438
Deferred revenue, net of current portion 2,495 3,107 4,596
Income tax liability 187 180 151
Other long-term liabilities 538 699 1,029
Total liabilities 26,583 26,550 26,214
Stockholders' equity 49,334 67,694 80,709
Total liabilities and stockholders' equity $ 75,917 $ 94,244 $ 106,923
(in thousands)
Three Months Ended
September 30, September 30,
2015 2014
Cash flows from operating activities:
Net loss $ (957) $ (2,636)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation 1,044 980
Depreciation and amortization 290 329
Other (32) 129
Changes in assets and liabilities:
Accounts receivable (94) (1,234)
Inventories 42 (1,076)
Accounts payable (938) 690
Accrued liabilities 1,230 1,500
Deferred revenue (801) 202
Other (398) (146)
Net cash used in operating activities (614) (1,262)
Cash flows from investing activities:
Acquisition of property, equipment and software (25) (107)
Net change in marketable investments 16,941 1,226
Net cash provided by investing activities 16,916 1,119
Cash flows from financing activities:
Repurchases of common stock (18,872)
Proceeds from exercise of stock options and employee stock purchase plan 1,046 655
Payments on capital lease obligations (48) (37)
Net cash provided by (used in) financing activities (17,874) 618
Net increase (decrease) in cash and cash equivalents (1,572) 475
Cash and cash equivalents at beginning of period 11,627 10,902
Cash and cash equivalents at end of period $ 10,055 $ 11,377
Supplemental disclosure of non-cash items:
Repurchase of common stock acquired but not settled $ 604 $ —
(in thousands, except percentage data)
Three Months Ended % Change
Q3 Q3 Q3 '15 Vs
2015 2014 Q3 '14
Revenue By Geography:
United States $ 13,206 $ 7,607 +74%
International 9,879 11,119 -11%
$ 23,085 $ 18,726 +23%
International as a percentage of total revenue 43% 59%
Revenue By Product Category:
-North America $ 10,830 $ 6,018 +80%
-Rest of the World 6,562 6,904 -5%
Total Products 17,392 12,922 +35%
Service 4,288 4,317 -1%
Hand Piece Refills 671 824 -19%
Skincare 734 663 +11%
$ 23,085 $ 18,726 +23%
Three Months Ended
Q3 Q3
2015 2014
Pre-tax Stock-Based Compensation Expense:
Cost of revenue $ 112 $ 145
Sales and marketing 311 195
Research and development 148 167
General and administrative 473 473
$ 1,044 $ 980

CONTACT: Cutera, Inc. Ron Santilli Chief Financial Officer 415-657-5500 Investor Relations John Mills Integrated Corporate Relations, Inc. 646-277-1254

Source:Cutera, Inc.